PATH | VRL
Menu

Antibody Responses Among Adolescent Females Receiving the Quadrivalent HPV Vaccine Series Corresponding to Standard or Non-Standard Dosing Intervals

This article, published in Vaccine, reports on a study to assess antibody levels when dose 2 and/or dose 3 of the 3-dose quadrivalent human papillomavirus (HPV) vaccine were administered on schedule or delayed. The authors found that antibody responses were not significantly lower for any of the delayed dosing groups when compared to the on time group, suggesting that delays do not interfere with immune responses after completion of the 3-dose series. ABSTRACT ONLY. (Learn how users in developing countries can gain free access to journal articles.)

Author: Russell K, Dunne E, Kemper AR, et al.

Published: 2015

» Visit web page (English)

(Located at www.sciencedirect.com)

Citation: Russell K, Dunne EF, Kemper AR. Antibody Responses Among Adolescent Females Receiving the Quadrivalent HPV Vaccine Series Corresponding to Standard or Non-Standard Dosing Intervals. Vaccine. 2015;33(16):1953-1958.

Resource types: Peer-reviewed journal

Diseases/vaccines: Human papillomavirus (HPV)

Topics: Vaccine safety and performance, Disease/vaccine specific information

Regions: North America and Europe